Neogene Therapeutics Stock

neogene.comBioTechFounded: 2018Funding to Date: $125MM

Neogene Therapeutics develops personalized engineered T cell therapies for a broad spectrum of cancers.

Enterprise Value (based on primary financings)

Register for Details

For more details on financing and valuation for Neogene Therapeutics, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Other companies like Neogene Therapeutics in the BioTech sector

Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.89B
Sector
Last Round Est. Valuation
$872.62MM
Sector
Last Round Est. Valuation
$486.63MM
Sector
Last Round Est. Valuation
$197.73MM
Sector
Last Round Est. Valuation
$50.4MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$185MM